Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration

Published:2018-11-28 Issue:1 Volume:9 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

Scarfe Lauren,Taylor Arthur,Sharkey Jack,Harwood Rachel,Barrow Michael,Comenge Joan,Beeken Lydia,Astley Cai,Santeramo Ilaria,Hutchinson Claire,Ressel Lorenzo,Smythe Jon,Austin Eric,Levy Raphael,Rosseinsky Matthew J.,Adams Dave J.,Poptani Harish,Park Brian K.,Murray Patricia,Wilm Bettina

Funder

Medical Research Council

FP7 People: Marie-Curie Actions

Alder Hey Children's NHS Foundation Trust

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13287-018-1076-x.pdf

Reference68 articles.

1. Buzhor E, Leshansky L, Blumenthal J, Barash H, Warshawsky D, Mazor Y, Shtrichman R. Cell-based therapy approaches: the hope for incurable diseases. Regen Med. 2014;9:649–72.

2. Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, Baty R, Graziano EI, Proto Marco B, Caron A, et al. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med. 2015;4:389–400.

3. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7:e47559.

4. Toyserkani N, Gustaf Jørgensen M, Tabatabaeifar S, Jensen C, Sheikh S, Sørensen J. Concise review: a safety assessment of adipose-derived cell therapy in clinical trials: a systematic review of reported adverse events: safety of adipose-derived cell therapy. Stem Cells Transl Med. 2017;6:1786–94.

5. Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med. 2014;34:695–704.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges;Signal Transduction and Targeted Therapy;2024-09-13

2. Stem Cell-Based Acellular Therapy: Insight into Biogenesis, Bioengineering and Therapeutic Applications of Exosomes;Biomolecules;2024-07-03

3. Exosomes, and the potential for exosome‐based interventions against COVID‐19;Reviews in Medical Virology;2024-06-25

4. Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics;Journal of Xenobiotics;2024-06-24

5. Precision Delivery of Human Bone Marrow-Derived Mesenchymal Stem Cells Into the Pancreas Via Intra-arterial Injection Prevents the Onset of Diabetes;Stem Cells Translational Medicine;2024-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3